Viridian Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2024 | 11.18 M | $254.42 M | 16.82% | 16.84% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.80 M | $109.29 M | 100.00% | 7.23% |
| VANGUARD GROUP INC | 11/13/2024 | 4.42 M | $100.56 M | 32.11% | 6.65% |
| VR ADVISER, LLC | 11/14/2024 | 3.88 M | $88.33 M | 0.00% | 5.85% |
| DEEP TRACK CAPITAL, LP | 11/14/2024 | 3.75 M | $85.33 M | -4.41% | 5.65% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2024 | 3.45 M | $78.39 M | 86.68% | 5.19% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2024 | 2.90 M | $65.88 M | -0.02% | 4.36% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 2.81 M | $63.99 M | 72.36% | 4.23% |
| COMMODORE CAPITAL LP | 11/14/2024 | 2.55 M | $58.02 M | 0.87% | 3.84% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2024 | 2.51 M | $57.13 M | 43.50% | 3.78% |
| NOVO HOLDINGS A/S | 10/24/2024 | 2.39 M | $54.26 M | 19.25% | 3.59% |
| STATE STREET CORP | 11/14/2024 | 2.38 M | $54.14 M | -14.16% | 3.58% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 2.24 M | $51.03 M | 61.02% | 3.38% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 2.20 M | $50.11 M | 10.24% | 3.32% |
| MAVERICK CAPITAL LTD | 11/14/2024 | 2.00 M | $45.44 M | -39.63% | 3.01% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.99 M | $45.31 M | 100.00% | 3.00% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 1.96 M | $44.56 M | 100.00% | 2.95% |
| VIVO CAPITAL, LLC | 11/13/2024 | 1.68 M | $38.18 M | 0.00% | 2.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.49 M | $33.98 M | 5.81% | 2.25% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 1.21 M | $27.41 M | 100.00% | 1.81% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.03 M | $23.33 M | 0.32% | 1.54% |
| MORGAN STANLEY | 11/14/2024 | 1.01 M | $22.97 M | 215.03% | 1.52% |
| OCTAGON CAPITAL ADVISORS LP | 11/14/2024 | 870,000 | $19.79 M | 40.32% | 1.31% |
| YIHENG CAPITAL MANAGEMENT, L.P. | 11/12/2024 | 847,891 | $19.29 M | -10.57% | 1.28% |
| WOODLINE PARTNERS LP | 11/14/2024 | 818,995 | $18.63 M | 104.28% | 1.23% |
| SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 763,118 | $17.36 M | 423.57% | 1.15% |
| GREAT POINT PARTNERS LLC | 11/13/2024 | 750,000 | $17.06 B | 50.00% | 1.13% |
| CANDRIAM S.C.A. | 11/13/2024 | 749,804 | $17.06 M | 0.00% | 1.13% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 739,253 | $16.82 M | -26.07% | 1.11% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2024 | 736,595 | $16.76 M | 0.00% | 1.11% |
| EVERSEPT PARTNERS, LP | 11/14/2024 | 691,232 | $15.73 M | 21.81% | 1.04% |
| MARSHALL WACE, LLP | 11/14/2024 | 684,799 | $15.58 M | 838.42% | 1.03% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 668,036 | $15.20 M | 192.76% | 1.01% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 10/21/2024 | 633,090 | $14.40 M | 100.00% | 0.95% |
| WALLEYE CAPITAL LLC | 11/14/2024 | 560,007 | $12.74 M | 30.05% | 0.84% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2024 | 525,000 | $11.94 M | 250.00% | 0.79% |
| CUTTER CAPITAL MANAGEMENT, LP | 11/14/2024 | 518,677 | $11.80 M | 100.00% | 0.78% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 516,213 | $11.74 M | 6.67% | 0.78% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 499,977 | $11.37 M | 100.00% | 0.75% |
| FISHER ASSET MANAGEMENT, LLC | 11/12/2024 | 494,924 | $11.26 M | 25.14% | 0.75% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 482,136 | $10.97 M | 14.84% | 0.73% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 444,800 | $10.12 M | -15.55% | 0.67% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 442,334 | $10.06 M | 26.51% | 0.67% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2024 | 425,000 | $9.67 M | 100.00% | 0.64% |
| JPMORGAN CHASE & CO | 11/08/2024 | 400,351 | $9.11 M | 218.47% | 0.60% |
| LORD, ABBETT & CO. LLC | 12/13/2024 | 391,958 | $8.92 M | 100.00% | 0.59% |
| JANE STREET GROUP, LLC | 11/15/2024 | 351,153 | $7.99 M | 210.55% | 0.53% |
| BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 339,089 | $7.71 M | 100.00% | 0.51% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 327,080 | $7.44 M | 204.03% | 0.49% |
| EAGLE ASSET MANAGEMENT INC | 11/12/2024 | 313,130 | $7.89 M | -16.15% | 0.47% |
Viridian Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 182 institutional investors and hedge funds held shares of Viridian Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 11.18 M
BlackRock Funding, Inc. /DE: 4.8 M
VANGUARD GROUP INC: 4.42 M
VR Adviser, LLC: 3.88 M
Deep Track Capital, LP: 3.75 M
Fairmount Funds Management LLC: 3.45 M
130.50% of Viridian Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 92.09 M shares in the last 24 months. This purchase volume represents approximately $1.78 B in transactions.